Breast Cancer Meeting Highlights - Page 2 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 2 of 14

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
Her2 Posters Utilizing VeraTag Assays to be presented at SABCS Hopeful	12-12-2007 02:51 PM by Hopeful	0	2,003
BC patients w/1-3 positive nodes and low risk 70-gene profile have excellent survival Hopeful	12-17-2007 08:23 AM by Hopeful	0	1,389
Her2 Recurrence Rates pre-Herceptin Hopeful	12-16-2007 02:40 PM by Andrea Barnett Budin	9	2,699
Comparison of joint problems as reported by patients in a randomised adjuvant trial Hopeful	12-14-2007 02:43 PM by Hopeful	0	1,629
Impact of ERBB2 on prognosis and microarray data Hopeful	12-14-2007 02:45 PM by Hopeful	0	1,654
The clinical significance of polysomy 17 in the HER2+ N9831 intergroup adjuvant trast Hopeful	12-14-2007 02:48 PM by Hopeful	0	1,603
Mechanism of action of herceptin killing of HER-2+ breast cancer cells under in vitro Hopeful	12-14-2007 02:49 PM by Hopeful	0	1,635
AI's in early breast cancer toxicity and adherence Hopeful	12-14-2007 03:14 PM by Hopeful	0	1,908
Change in annual recurrence rates over the last 10 years - NORA study Hopeful	12-14-2007 03:36 PM by Hopeful	0	1,923
Confirmatory Tissue Biopsy for BC mets strongly recommended Hopeful	12-17-2007 08:25 AM by Hopeful	0	1,314
Multidisciplinary management of menopause symptoms after breast cancer Hopeful	12-17-2007 08:27 AM by Hopeful	0	1,231
For R.B - Her2 and fatty acid synthase in bc cells Hopeful	12-17-2007 08:29 AM by Hopeful	0	1,392
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,210
Determination of HER2 amplification - when should chromosome 17 also be determined Hopeful	12-14-2008 05:55 PM by Becky	2	1,912
BC patients unknowingly dosing themselves with estrogen by using topical moisturizers Hopeful	12-28-2008 01:28 PM by Rich66	9	2,662
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,696
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,468
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,392
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,423
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,538
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,468
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,350
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,672
HER-2/neu expression/amplification is not stable during tumor progression Hopeful	12-12-2008 07:47 AM by Hopeful	0	1,536
PR receptor levels are associated with time to AI treatment failure Hopeful	12-12-2008 07:49 AM by Hopeful	0	1,681
HER2 amplification does not alter outcome in small (1 cm) tumors Hopeful	12-12-2008 07:50 AM by Hopeful	0	1,555
HER2 amplification predicts breast cancer recurrence but not overall survival Hopeful	02-03-2009 09:30 PM by gdpawel	3	2,502
Low penetrance breast cancer predisposition SNPs are site specific Hopeful	12-12-2008 07:52 AM by Hopeful	0	2,015
Pooled cardiac safety analysis of patients with HER2+ MBC receiving trastuzumab Hopeful	12-12-2008 07:54 AM by Hopeful	0	1,626
Chronobiological rhythms of cytokines level of breast cancer Hopeful	03-19-2009 07:00 AM by Hopeful	0	1,745
Presence of an in-situ component is associated with reduced biological aggressiveness Hopeful	03-18-2009 06:17 AM by Hopeful	0	1,575
The coamplification pattern of HER2/NEU amplicon and its clinical significance Hopeful	03-18-2009 06:18 AM by Hopeful	0	1,467
Tumor size vs Her2 amplification in post-meno, ER+ tamoxifen tx pts Hopeful	03-18-2009 06:22 AM by Hopeful	0	1,684
CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome Hopeful	03-18-2009 06:23 AM by Hopeful	0	1,504
The timing of recurrence after the surgery of breast cancer Hopeful	03-18-2009 06:24 AM by Hopeful	0	1,794
Is there a promotion of metastasis by autologeous breast reconstruction in patients? Hopeful	03-18-2009 06:25 AM by Hopeful	0	1,671
Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiother Hopeful	03-19-2009 06:52 AM by Hopeful	0	1,675
Radiofrequency ablation of early breast cancer followed by delayed surgical resection Hopeful	03-19-2009 06:53 AM by Hopeful	0	1,544
Primary endocrine therapy versus chemo in postmen pts w/ ER+ bc: 5 yr results Hopeful	03-19-2009 07:02 AM by Hopeful	0	1,682
Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer pts Hopeful	03-19-2009 07:04 AM by Hopeful	0	1,781
Combined ER and HER-targeted therapy in breast cancer treatment Hopeful	03-21-2009 10:23 PM by Jackie07	1	1,936
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen Hopeful	05-19-2009 06:32 AM by Hopeful	0	1,504
Treatment of node-negative infra-centimetric HER2+ invasive breast carcinomas Hopeful	05-19-2009 06:33 AM by Hopeful	0	1,411
PIK3CA gene expression signature and prognosis within the luminal-B ER+ bc Hopeful	05-19-2009 06:36 AM by Hopeful	0	1,618
Expression profile of CTC and corresponding tumors in primary breast cancer patients Hopeful	05-19-2009 06:38 AM by Hopeful	0	1,639
trastuzumab-related cardiac dysfunction in the HERA Trial with 3.6 years follow- up Hopeful	05-19-2009 06:40 AM by Hopeful	0	1,671
trial of acupuncture for the management of AI associated joint symptoms Hopeful	05-19-2009 06:41 AM by Hopeful	0	1,492
Association between HER2/neu overexpression and calcifications in breast cancer Hopeful	05-20-2009 06:23 AM by Hopeful	0	1,505
Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy Hopeful	05-20-2009 06:26 AM by Hopeful	0	2,048
Risk factors associated with trastuzumab-associated cardiac toxicity Hopeful	05-20-2009 06:28 AM by Hopeful	0	1,655
HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer Hopeful	05-20-2009 06:30 AM by Hopeful	0	1,525
Long-term follow-up and factors of survival of HER-2 positive breast cancer patients Hopeful	05-20-2009 06:31 AM by Hopeful	0	1,618
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype Hopeful	05-20-2009 08:24 AM by bejuce	1	1,853
Trastuzumab cardiotoxicity: FDA review Hopeful	05-21-2009 06:44 AM by Hopeful	0	1,640
Sensitivity to endocrine therapy of PR+/ER- patients and ER+/PR- patients with HER2+ Hopeful	05-21-2009 06:46 AM by Hopeful	0	1,614
Weight gain after adjuvant TAC (docetaxel, doxorubicin, and cyclophosphamide) chemo Hopeful	05-21-2009 06:50 AM by Hopeful	0	1,963
Surgery vs primary endocrine therapy for elderly women Hopeful	05-21-2009 06:51 AM by Hopeful	0	1,553
Off-label drug use in women with breast cancer Hopeful	05-21-2009 06:59 AM by Hopeful	0	1,673
Pertuzumab monotherapy following trastuzumab-based treatment Hopeful	05-28-2009 12:39 AM by Rich66	1	1,213
Complications associated with erythropoietin stimulating agents in mbc patients Hopeful	05-22-2009 06:41 AM by Hopeful	0	1,391
Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in Hopeful	05-22-2009 06:44 AM by Hopeful	0	1,227
Characteristics of subsequent breast cancers in patients with benign breast disease Hopeful	06-01-2009 07:34 AM by Hopeful	0	1,073
What is the evidence for rechallenging with anthracyclines or taxanes in MBC? Hopeful	06-01-2009 07:39 AM by Hopeful	0	1,051
Differential timing and patterns of recurrence among breast cancer subtypes Hopeful	06-01-2009 07:40 AM by Hopeful	0	1,016
Impressive survival data with semimetronomic oral chemo Hopeful	06-02-2009 07:06 AM by Hopeful	0	930
Cardiac safety of the lapatinib/letrozole combination Hopeful	06-02-2009 07:08 AM by Hopeful	0	1,120
Concordant HER2 status between malignant CSF cells and primary breast carcinoma tissu Hopeful	06-02-2009 07:10 AM by Hopeful	0	1,055
Multifactorial CNS relapse susceptibility in HER2-positive breast cancer patients Hopeful	06-02-2009 07:12 AM by Hopeful	0	983
CA 125 in the early detection of metastatic breast cancer Hopeful	06-02-2009 07:15 AM by Hopeful	0	790
Detection of locally advanced breast cancer in the I-SPY TRIAL Hopeful	06-03-2009 06:34 AM by Hopeful	0	709
A study of lavender and tea tree oils on postmenopausal FSH levels and hot flash seve Hopeful	06-03-2009 07:26 PM by Laurel	1	1,088
Effect of simvastatin on the pharmacokinetics of anastrozole Hopeful	06-03-2009 06:38 AM by Hopeful	0	761
Evaluation of the effect of screening on the detection of good and poor prognosis bc Hopeful	06-04-2009 06:22 AM by Hopeful	0	824
Factors leading to the decision for contralateral prophylactic mastectomy Hopeful	06-04-2009 06:23 AM by Hopeful	0	845
Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy Hopeful	06-04-2009 06:26 AM by Hopeful	0	870

Page 2 of 14

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 04:30 AM.